Steward Partners Investment Advisory, LLC Rocket Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 7,500 shares of RCKT stock, worth $130,875. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,500
Previous 7,500
-0.0%
Holding current value
$130,875
Previous $202,000
20.3%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RCKT
# of Institutions
195Shares Held
92.4MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$309 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$160 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$101 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$75.5 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.32B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...